// App-Quantinova.ai

2639 : Preclinical evaluation and biomarker identification for the anti-LGR5 mAb BNC101 in K-Ras mutant CRC and other solid tumor indications

Researchers

Presenter

  • Peter Chu

Principal Investigators

  • Kristen Smith

  • Farbod Shojaei

  • Colin Walsh

  • John Norton

  • Jose Iglesias

  • Christopher Reyes

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Bionomics

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Pancreatic cancer

  • Solid malignancies

  • Small cell lung cancer

  • Triple-negative breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • BNC101

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved